Buyback yield (TTM)
N/A
Shareholder yield (TTM)
3.72%
5Y share count change
-3.3%
Buyback spend (TTM)
N/A
Cumulative buybacks
$47.73B
Key takeaways
- Diluted share count is down 3.3% over the last ~5 fiscal years — buybacks are net-shrinking the share base.
- TTM repurchases used about 0% of free cash flow remaining after dividends.
Dividend & buyback yield over time for CVS Health (CVS)
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Diluted vs basic shares (annual) for CVS Health (CVS)
Diluted weighted-average shares are the EPS denominator — a falling count means buybacks are outpacing SBC dilution.
Year-over-year change in diluted shares for CVS Health (CVS)
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Cash buyback spend over time for CVS Health (CVS)
Latest: $0.00
Overview
As of the 2025 fiscal year, CVS Health (CVS) reported buyback spend of $0.00 – plunged 100.0% year-over-year.
Through 2015–2025 (10 years), CVS Health buyback spend delivered a -100.0% annualised rate; with a net decline across the window.
CVS Health buyback spend peaked at $5.37B in 2007; the latest annual figure is $0.00 in 2025 (100.0% below peak).
The highest annual buyback spend of $5.37B was reported in 2007. The lowest in the available history was $0.00 in 1991.
CVS Health Buyback Spend 2025: $0.00
2025's buyback spend for CVS Health came in at $0.00, plunged 100.0% below 2024.
CVS Health Buyback Spend 2024: $3.02B
CVS Health posted buyback spend of $3.02B in 2024, surged 50.2% from 2023.
CVS Health Buyback Spend 2023: $2.01B
In 2023, CVS Health reported buyback spend of $2.01B, plunged 42.5% below 2022.
CVS Health Buyback Spend 2022: $3.50B
CVS Health buyback spend in 2022 was $3.50B.
CVS Health Buyback Spend 2021: $0.00
CVS Health buyback spend in 2021 was $0.00.
See more financial history for CVS Health (CVS).
Buyback, SBC & dilution history
Buyback spend, SBC, net dilution effect, and share count.
| 2025 | $0.00 | $535.00M | −$535.00M | — | 1.27B | +0.7% | |
| 2024 | $3.02B | $540.00M | $2.48B | 5.35% | 1.26B | -2.2% | |
| 2023 | $2.01B | $588.00M | $1.42B | 1.98% | 1.29B | -2.5% | |
| 2022 | $3.50B | $447.00M | $3.05B | 2.87% | 1.32B | -0.5% | |
| 2021 | $0.00 | $484.00M | −$484.00M | — | 1.33B | +1.1% | |
| 2020 | $0.00 | $400.00M | −$400.00M | — | 1.31B | +0.7% | |
| 2019 | $0.00 | $453.00M | −$453.00M | — | 1.30B | +25.0% | |
| 2018 | $0.00 | $280.00M | −$280.00M | — | 1.04B | +2.0% | |
| 2017 | $4.36B | $234.00M | $4.13B | 5.93% | 1.02B | -5.1% | |
| 2016 | $4.46B | $222.00M | $4.24B | 5.31% | 1.08B | -4.2% | |
| 2015 | $5.00B | $230.00M | $4.77B | 4.62% | 1.13B | -3.7% | |
| 2014 | $4.00B | $165.00M | $3.84B | 3.68% | 1.17B | -4.6% | |
| 2013 | $3.98B | $141.00M | $3.83B | 4.66% | 1.23B | -4.2% | |
| 2012 | $4.33B | $132.00M | $4.20B | 7.22% | 1.28B | -5.0% | |
| 2011 | $3.00B | $135.00M | $2.87B | 5.67% | 1.35B | -2.2% | |
| 2010 | $1.50B | $150.00M | $1.35B | 3.17% | 1.38B | -5.0% | |
| 2009 | $2.48B | $165.00M | $2.31B | 5.55% | 1.45B | -1.3% | |
| 2008 | $23.00M | $92.00M | −$69.00M | 0.06% | 1.47B | +7.1% | |
| 2007 | $5.37B | $0.00 | $5.37B | 9.38% | 1.37B | +60.8% | |
| 2006 | $0.00 | $0.00 | $0.00 | — | 0.85B | +1.4% | |
| 2005 | $0.00 | $0.00 | $0.00 | — | 0.84B | +2.3% | |
| 2004 | $0.00 | $0.00 | $0.00 | — | 0.82B | +1.7% | |
| 2003 | $0.00 | $0.00 | $0.00 | — | 0.81B | -0.3% | |
| 2002 | $0.00 | $0.00 | $0.00 | — | 0.81B | +1.7% | |
| 2001 | $129.00M | $0.00 | $129.00M | 1.13% | 0.80B | -0.3% | |
| 2000 | $163.20M | $0.00 | $163.20M | — | 0.80B | -2.3% | |
| 1999 | $0.00 | $0.00 | $0.00 | — | 0.82B | +0.9% | |
| 1998 | $0.00 | $0.00 | $0.00 | — | 0.81B | +2.5% | |
| 1997 | $0.00 | $0.00 | $0.00 | — | 0.79B | +85.4% | |
| 1996 | $0.00 | $0.00 | $0.00 | — | 0.43B | — | |
| 1995 | $39.10M | $0.00 | $39.10M | — | — | — | |
| 1994 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1993 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1992 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1991 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1990 | $3.80M | $0.00 | $3.80M | — | — | — | |
| 1989 | $357.50M | $0.00 | $357.50M | — | — | — |
- 2025$0.00
- 2024$3.02B
- 2023$2.01B
- 2022$3.50B
- 2021$0.00
- 2020$0.00
- 2019$0.00
- 2018$0.00
- 2017$4.36B
- 2016$4.46B
- 2015$5.00B
- 2014$4.00B
- 2013$3.98B
- 2012$4.33B
- 2011$3.00B
- 2010$1.50B
- 2009$2.48B
- 2008$23.00M
- 2007$5.37B
- 2006$0.00
- 2005$0.00
- 2004$0.00
- 2003$0.00
- 2002$0.00
- 2001$129.00M
- 2000$163.20M
- 1999$0.00
- 1998$0.00
- 1997$0.00
- 1996$0.00
- 1995$39.10M
- 1994$0.00
- 1993$0.00
- 1992$0.00
- 1991$0.00
- 1990$3.80M
- 1989$357.50M
Buybacks vs stock-based compensation for CVS Health (CVS)
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 0.00×.
Buybacks vs dividends (share of cash returned) for CVS Health (CVS)
How CVS Health splits cash returned to shareholders between dividends and buybacks.
Sector peers by buyback spend
Companies in the same sector as CVS Health, ranked by their latest buyback spend.
| $5.95B | |
| $5.54B | |
| $5.08B | |
| $4.11B | |
| $980.00M | |
| $216.35M | |
| $0.00 | |
| $0.00 |
- $5.95B
- $5.54B
- $5.08B
- $4.11B
- $980.00M
- $216.35M
- $0.00
- $0.00
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $3.99B (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Data & methodology
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation